Components of the metabolic syndrome and incidence of diabetes in elderly Italians: The Italian Longitudinal Study on Aging

Atherosclerosis

Volumn 187, Issue 2, 2006, Pages 385-392

  Noale, Marianna ^a   Maggi, Stefania ^a   Marzari, Chiara ^a   Limongi, Federica ^a   Gallina, Pietro ^a   Bianchi, Daniele ^a   Crepaldi, Gaetano ^a  

^a CNR   (Italy)

Author keywords

Components; Diabetes incidence; Elderly; Factor analysis; Metabolic syndrome

Indexed keywords

AGED; AGING; ARTICLE; BLOOD PRESSURE; BODY SIZE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE ASSOCIATION; FACTORIAL ANALYSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; ITALY; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL MODEL; VARIMAX ROTATION;

AGED; AGED, 80 AND OVER; AGING; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; ITALY; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

EID: 33745493140     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.09.018     Document Type: Article

References (35)

1. Avogaro P., Crepaldi G., Enzi G., and Tiengo A. Association of hyperlipemia, diabetes mellitus and mild obesity. Acta Diabetol Lat 4 (1967) 572-590
2. Grundy S.M. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89 6 (2004) 2595-2600
3. Sakkinen P.A., Wahl P., Cushman M., Lewis M.R., and Tracy R.P. Clustering of procoagulation, inflammation and fibrinolysis variables with metabolic factors in insulin resistence syndrome. Am J Epidemiol 152 10 (2000) 897-907
4. Meigs J.B., D'Agostino R.B., Wilson P.W., et al. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46 10 (1997) 1594-1600
5. Oh J.-Y., Hong Y.S., Sung Y.A., and Barrett-Connor E. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diab Care 27 8 (2004) 2027-2032
6. Hanson R.L., Imperatore G., Bennett P.H., and Knowler W.C. Components of the "Metabolic Syndrome" and incidence of type 2 diabetes. Diabetes 51 (2002) 3120-3127
7. Wang J.J., Qiao Q., Miettinen M., et al. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diab Care 27 10 (2004) 2429-2437
8. Shen B.J., Todaro J.F., Niaura R., et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 157 8 (2003) 701-711
9. Ford E.S. Factor analysis and defining the metabolic syndrome. Ethn Dis 13 4 (2003) 429-437
10. Ghosh A. Factor analysis of metabolic syndrome among the middle-aged Bengalee Hindu men of Calcutta India. Diab Metab Res Rev 21 1 (2005) 58-64
11. Choi K.M., Lee J., Kim K.B., et al. Factor analysis of the metabolic syndrome among elderly Koreans-the southwest Seoul Study. Diab Med 20 2 (2003) 99-104
12. Lempiainen P., Mykkanen L., Pyorala K., Laakso M., and Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100 2 (1999) 123-128
13. Novak S., Stapleton L.M., Litaker J.R., and Lawson K.A. A confirmatory factor analysis evaluation of the coronary heart disease risk factors of metabolic syndrome with emphasis on the insulin resistance factor. Diab Obes Metab 5 6 (2003) 388-396
14. Gray R.S., Fabsitz R.R., Cowan L.D., et al. Risk factor clustering in the insulin resistance syndrome The Strong Heart Study. Am J Epidemiol 148 9 (1998) 869-878
15. Edwards K.L., Burchfiel C.M., Sharp D.S., et al. Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol 148 5 (1998) 441-447
16. Kue Young T., Chateau D., and Zhang M. Factor analysis of ethnic variation in the multiple metabolic (insulin resistance) syndrome in three Canadian populations. Am J Hum Biol 14 5 (2002) 649-658
17. Cameron A.J., Shaw J.E., and Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin N Am 33 (2004) 351-375
18. Maggi S., Zucchetto M., Grigoletto F., et al., for the ILSA group. The Italian Longitudinal Study on Aging (ILSA): design and methods. Aging Clin Exp Res 6 (1994) 464-473
19. The Italian Longitudinal Study on Aging Working Group. Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. Int J Epidemiol 1997;26:995-1002.
20. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
21. Perissinotto E., Pisent C., Sergi G., Grigoletto F., Enzi G., and for the ILSA Working Group. Anthropometric measurements in the elderly: age gender differences. Br J Nutr 87 (2002) 1-11
22. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. JAMA 2001;285:2486-97.
23. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 109 3 (2004) 433-438
24. Reaven G.M. Banting lecture role of insulin resistance in human disease. Diabetes 37 12 (1988) 1595-1607
25. Matsuda M., and Defonzo R.A. In vivo measurement of insulin sensitivity in humans. In: Draznin B., and Rizza R. (Eds). Clinical research in diabetes and obesity vol. 1 (1997), Humana, Totowa, NJ 23-65
26. Ferrannini E., Haffner S.M., Mitchell B.D., and Stern M.P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34 6 (1991) 416-422
27. Haffner S., and Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 108 (2003) 1541-1545
28. Groop L., Forsblom C., Lehtovirta M., et al. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45 11 (1996) 1585-1593
29. Lemieux I., Almeras N., Mauriege P., et al. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 18 7 (2002) 725-732
30. Despres J.P., Lemieux I., and Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 322 7288 (2001) 716-720
31. Sonnenberg G.E., Krakower G.L., and Kissebah A.H. A novel pathway to the manifestations of metabolic syndrome. Obes Res 12 2 (2003) 180-186
32. Kobayashi K. Adipokines: therapeutic targets for metabolic syndrome. Curr Drug Targets 6 4 (2005) 525-529
33. Thayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184 4 (2005) 285-293
34. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care 1997;20:1183-97.
35. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diab care 26 (2003) 3160-3167